RIGL - Rigel Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts7777
Avg. Estimate-0.13-0.13-0.27-0.3
Low Estimate-0.15-0.15-0.36-0.48
High Estimate-0.12-0.11-0.21-0.13
Year Ago EPS-0.12-0.07-0.4-0.27
Revenue EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts6666
Avg. Estimate13.75M15.74M102.83M110.79M
Low Estimate10.8M11M89.1M74.5M
High Estimate16M19.07M113.87M148M
Year Ago Sales10.41M20.86M59.29M102.83M
Sales Growth (year/est)32.10%-24.50%73.40%7.70%
Earnings History6/29/20199/29/201912/30/20193/30/2020
EPS Est.-0.14-0.11-0.080.13
EPS Actual-0.12-0.07-0.10.13
Difference0.020.04-0.020
Surprise %14.30%36.40%-25.00%0.00%
EPS TrendCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Current Estimate-0.13-0.13-0.27-0.3
7 Days Ago-0.13-0.13-0.27-0.31
30 Days Ago-0.13-0.13-0.27-0.31
60 Days Ago-0.12-0.11-0.22-0.24
90 Days Ago-0.12-0.11-0.22-0.24
EPS RevisionsCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1111
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesRIGLIndustrySectorS&P 500
Current Qtr.-8.30%N/AN/AN/A
Next Qtr.-85.70%N/AN/AN/A
Current Year32.50%N/AN/AN/A
Next Year-11.10%N/AN/AN/A
Next 5 Years (per annum)70.00%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A